Concepedia

2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: Optimization via array synthesis

Lalgudi S. Harikrishnan, Muthoni G. Kamau, Timothy F. Herpin, George Morton, Yalei Liu, Christopher B. Cooper, Mark Salvati, Jennifer X. Qiao, Tammy C. Wang, Leonard P. Adam,

Bioorganic & Medicinal Chemistry Letters · 2008 · 38 citations · 7 references

DOIFull text

Open access

Concepts

References

7

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

William P. Castelli, Robert J. Garrison, Peter W.F. Wilson et al. · PubMed · 1986 · 2.3K citations

, , +12

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

George G. Rhoads, C. L. Gulbrandsen, Abraham Kagan · New England Journal of Medicine · 1976 · 881 citations

, , +12

Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein

Ronald W. Clark, Tamara A. Sutfin, Roger B. Ruggeri et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 371 citations · Full text

, , +13

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

JAMA · 1986 · 325 citations

, , +15

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 277 citations

, , +15